| Sep 4, 2025 | Octave Bioscience | $51.1M Debt / Series C | — | BlueCross BlueShield Venture Partners, Brook Byers, Casdin Capital, Intermountain Ventures, Merck, Northpond Ventures, Novartis, Section 32, Silicon Valley Bank, Valhalla Charitable Foundation |
| Jul 26, 2023 | Octave Bioscience | $30.0M Series B Extension | Michael Rubin | Julian Harris, BlueCross BlueShield Venture Partners, Brook Byers, Casdin Capital, Deerfield Management, Echo Health Ventures, Lana Ghanem, Nickolas Mark, Merck, Northpond Ventures, Novartis, Rana Lonnen, Section 32 |
| May 18, 2023 | Prognos Health | $23.0M Other Equity | Marshall Wace, Safeguard Scientifics | Cigna Ventures, Hunt Holdings, Labcorp, Maywic Select Investments, Merck, Red & Blue Ventures |
| Mar 28, 2022 | Altibbi | $44.0M Series B | Abhishek Sharma, Lana Ghanem | DASH Ventures, Global Ventures |
| Mar 23, 2022 | Activ Surgical | $15.0M Series B Extension | Lana Ghanem | Emily Brown, David You |
| Mar 1, 2022 | Altoida | $14.0M Series A | M Ventures (Merck) | Fyrefly VC, Taiho Ventures, Tomahawk.VC, Alpana Ventures, btov Partners, HonorHealth, VI Partners |
| Jan 19, 2022 | NuvoAir | $11.0M Series A Extension | Lana Ghanem | — |
| Sep 1, 2021 | Click Therapeutics | $52.0M Series B | Uri Geiger, Alex Zisson | Eight Roads Ventures, Sanofi Ventures, Webtalk Ltd, Health Catalyst Capital, K2 HealthVentures, Revelation Partners, Ridgetop Health |
| Jul 1, 2020 | Lemonaid Health | $37.0M Series B | Alejandro Weinstein | Vasudev Bailey, Artis Ventures (AV), Correlation Ventures, Third Kind Ventures, Sierra Ventures |
| Nov 25, 2019 | Casca | $7.7M Other Equity / Series A | Tobias Lütke, Hikma Ventures, Khosla Ventures | First Star Ventures, Grey Sky Venture Partners, Pacific Health Ventures |
| May 1, 2019 | Pillo Health | $11.0M Series A | Larry Harper | BioAdvance, DreamIt Ventures, GIT1K, Civilization Ventures, Hackensack Meridian Health, Samsung Ventures |
| Aug 29, 2018 | Nebula Genomics | $4.3M Seed | — | Robert Nelsen, Fenbushi Capital, F-Prime Capital, GreatPoint Ventures, Heartbeat Labs, Hemi Ventures, Khosla Ventures, Tim Chang, Mirae Asset, Windham Venture Partners |
| Dec 1, 2017 | Prognos | $20.5M Series C | — | Craig Cimini, GIS Strategic Ventures, Hermed, Maywic Select Investments, Joe Volpe, Safeguard Scientifics |
| May 1, 2017 | Lemonaid Health | $11.0M Series A | Lana Ghanem, Novartis | Vasudev Bailey, Cathay Innovation, Correlation Ventures, Eight Roads Ventures, Firstminute Capital, F-Prime Capital Partners, Frst, Plug & Play Ventures, Third Kind Ventures, 415 Ventures, Adaptive Healthcare Fund, Vega Ventures |
| Oct 1, 2016 | Propeller Health | $22.0M Series C | — | Array Ventures, Bain Capital Ventures, Bowery Capital, Coelius Capital, ENIAC Ventures, Ensemble VC, Ligature, Math Capital, Oceans, QueensBridge Venture Partners, Social Capital, Tribe Capital, Anthony Saleh, Evan Cheng, Kim Perell, Lev Ekster, 3M Ventures, Lana Ghanem, Limited Ventures, Safeguard Scientifics, Rajeev Dadoo |
| Sep 1, 2016 | Chrono Therapeutics | $48.0M Series B | Kaiser Permanente Ventures | 5AM Ventures, Canaan Partners, SR One Capital Management, Asahi Kasei, Wende Hutton, Cota Capital, Emergent Medical Partners, Endeavour Vision, Fountain Healthcare Partners, GE Ventures, Mayo Clinic, Mission Bay Capital, Xeraya Capital |
